A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

Completed Successful FDA End-of-Phase 2 Meeting Following Positive Nebokitug Phase 2 SPRING Trial Resultsin Primary Sclerosing Cholangitis ...

Whether moderate doses of UDCA slow the progression of PSC-related liver disease remains unclear and, indeed, high doses of UDCA may be harmful. On the basis of available data it would be ...

The past year has been a transformative period for both Chemomab and the PSC field,” said Adi Mor, PhD, co-founder and Chief Executive Officer ...

and up to 14% of patients with IBD also developing PSC. This increases the chances of needing colon surgery and getting colon or liver cancer, needing a liver transplant, and the overall risks of ...

Drugs like alcohol, supplements, and various medications can also damage the liver. "Autoimmune issues—such as autoimmune hepatitis, PBC, PSC. Take care of your liver by watching what you put in ...